Q1 2024 Holdings
Filed 2024-05-15 | 57 holdings | $2.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $426.7M | 8,494,151 | 18.7% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $142.5M | 6,893,235 | 6.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $123.8M | 1,780,000 | 5.4% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $107.0M | 2,700,000 | 4.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $99.0M | 3,203,029 | 4.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $79.9M | 1,310,000 | 3.5% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $79.5M | 2,025,000 | 3.5% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $77.8M | 2,139,102 | 3.4% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $72.4M | 3,353,141 | 3.2% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $54.8M | 3,006,534 | 2.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $53.8M | 1,150,000 | 2.4% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $53.4M | 3,570,872 | 2.3% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $47.6M | 529,170 | 2.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $46.8M | 685,000 | 2.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $42.2M | 6,616,667 | 1.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $39.6M | 1,711,460 | 1.7% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $35.5M | 1,500,000 | 1.6% |
| CG Oncology Inc(CGON) | COM | 156944100 | $35.1M | 800,000 | 1.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $35.0M | 3,142,079 | 1.5% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $33.7M | 616,963 | 1.5% |
| Merus N V | COM | N5749R100 | $32.2M | 715,000 | 1.4% |
| Aerovate Therapeutics Inc | COM | 008064107 | $31.6M | 1,069,796 | 1.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $30.5M | 2,130,000 | 1.3% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $30.3M | 2,909,000 | 1.3% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $29.4M | 3,250,000 | 1.3% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $28.6M | 1,250,000 | 1.3% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $28.2M | 750,000 | 1.2% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $27.4M | 538,714 | 1.2% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $26.4M | 1,182,563 | 1.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $23.8M | 550,000 | 1.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $23.5M | 400,000 | 1.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $21.1M | 2,125,000 | 0.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $19.7M | 450,000 | 0.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $18.8M | 1,100,000 | 0.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $18.3M | 1,300,000 | 0.8% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $17.0M | 1,000,000 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $15.6M | 575,000 | 0.7% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $14.9M | 2,710,000 | 0.7% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $14.6M | 1,350,000 | 0.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $13.5M | 625,000 | 0.6% |
| Mersana Therapeutics Inc | COM | 59045L106 | $11.6M | 2,600,000 | 0.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $11.0M | 5,560,300 | 0.5% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $10.9M | 440,000 | 0.5% |
| Beam Therapeutics Inc(BEAM)Put | COM | 07373V105 | $9.9M | 300,000 | 0.4% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $9.5M | 3,295,273 | 0.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $9.5M | 250,000 | 0.4% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $9.2M | 515,000 | 0.4% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $8.1M | 300,000 | 0.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $7.8M | 125,000 | 0.3% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $6.3M | 561,600 | 0.3% |